The relation between human papilloma virus serotype infection and colposcopic, cytological and histopathological abnormalities among the Egyptian women: retrospective study

Objective. Correlating Human Papillomavirus (HPV) serotyping, the findings of PAP-smear, colposcopy with colposcopic directed biopsy. Sharing our epidemiological data guides the local health authorities to formalize national screening protocols. Patient and Methods . A retrospective study was conducted at the Gynecological clinic of a tertiary University Hospital during the period between 2015 to 2020. A total of 285 women's medical records were reviewed for epidemiological, clinical presentation and Pap smear, HPV serotypes, colposcopy findings, and colposcopic guided biopsy. The results were plotted and correlated based on histopathological results. Results. HPV substantial risk types were detected in 74 (25.8%), and minimal risk serotypes were detected in 28(9.7%). 16 positivity was evident in 13 (12.03%) patients, followed by HPV 31 serotype in 12(11.1%), HPV-51 detected in 11 (10.8%), HPV 18 positivity in 10 (10.02%), while HPV negative in 128 (44.7%). The sensitivity of colposcopy was higher than Pap smear (93.2% Vs 68.52%); however, its specificity was only 69.1% compared to 96.7% of the Pap smear. Our results demonstrated a high agreement between colposcopy and histology 95.36%. similarly, Pap smear and colposcopy agreement was high up to 98 %, but between Pap smear and histology was 84%. Conclusions. Pairing the result of HPV serotypes with the grade of abnormal cytology, colposcopic appearance, and histopathological findings could improve the early detection of preinvasive lesions.

[1]  A. Giannini,et al.  Loop Electrosurgical Excision Procedure and Cold Knife Conization: which is the best? A large retrospective study , 2022, Italian Journal of Gynaecology and Obstetrics.

[2]  Yue-xia Gao,et al.  Global, regional, and national burden of cervical cancer for 195 countries and territories, 2007–2017: findings from the Global Burden of Disease Study 2017 , 2021, BMC Women's Health.

[3]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[4]  A. Dell'Acqua,et al.  High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes. , 2021, Gynecologic oncology.

[5]  Jacques Ferlay,et al.  Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis , 2019, The Lancet. Global health.

[6]  Yanqing Ding,et al.  Prevalence and distribution of human papillomavirus genotypes among women with high‐grade squamous intraepithelial lesion and invasive cervical cancer in Ganzhou, China , 2018, Journal of clinical laboratory analysis.

[7]  B. Brown,et al.  Are colposcopy and electrical impedance spectroscopy complementary when used to detect high-grade cervical neoplasia? , 2018 .

[8]  E. J. Mayeaux,et al.  ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards , 2017, Journal of lower genital tract disease.

[9]  S. Vitale,et al.  Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice? , 2017, Updates in Surgery.

[10]  C. Adebamowo,et al.  Mycoplasma hominis and Mycoplasma genitalium in the Vaginal Microbiota and Persistent High-Risk Human Papillomavirus Infection , 2017, Front. Public Health.

[11]  N. Wentzensen,et al.  MANAGEMENT OF HPVAND ASSOCIATED CERVICAL LESIONS ( B BARRETTE , SECTION EDITOR ) HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease , 2013 .

[12]  Achim Schneider,et al.  Validity of the Colposcopic Criteria Inner Border Sign, Ridge Sign, and Rag Sign for Detection of High-Grade Cervical Intraepithelial Neoplasia , 2013, Obstetrics and gynecology.

[13]  M. Schiffman,et al.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer , 2012 .

[14]  W. Melchers,et al.  Evaluation of the SPF10-INNO LiPA Human Papillomavirus (HPV) Genotyping Test and the Roche Linear Array HPV Genotyping Test , 2006, Journal of Clinical Microbiology.

[15]  K. Syrjänen,et al.  Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping. , 2006, Anticancer research.

[16]  F. Bir,et al.  [Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay]. , 2004, Mikrobiyoloji bulteni.

[17]  S. Cavalcanti,et al.  Detection of human papillomavirus DNA by the hybrid capture assay. , 2003, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[18]  M. Lotfy,et al.  Detection of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cancer patients: Sharkia Governorate, Egypt. , 2011, Clinical laboratory.

[19]  J. Kaczorowski,et al.  Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[20]  Hagerstoten American society for colposcopy and cervical pathology. , 1999, Journal of lower genital tract disease.